Der Markt für Krebsimpfstoffe wird bis 2027 voraussichtlich 15.845,59 Millionen US-Dollar erreichen, nach 4.568,82 Millionen US-Dollar im Jahr 2019; Es wird geschätzt, dass der Markt von 2020 bis 2027 mit einer jährlichen Wachstumsrate von 17,2 % wachsen wird.
Die Krebsimpfstoffe helfen bei der Behandlung bestehender Krebserkrankungen oder verhindern die Entstehung von Krebs; Erstere werden als therapeutische Krebsimpfstoffe bezeichnet. Mehrere Impfstoffe sind autolog, da sie aus Proben von Krebspatienten hergestellt werden und solche Impfstoffe nur für diesen Patienten gelten. Es gibt zwei Arten von Krebsimpfstoffen: therapeutische Impfstoffe und präventive Impfstoffe. Cervarix-, Gardasil-, Gardasil-9- und Hepatitis B (HBV)-Impfstoffe (HEPLISAV-B) sind präventive Krebsimpfstoffe, während Sipuleucel-T (Provenge) therapeutische Krebsimpfstoffe sind. Der weltweite Markt für Krebsimpfstoffe wird durch Faktoren wie steigende Forschungs- und Entwicklungsausgaben von Pharmaunternehmen und zunehmende staatliche Unterstützung für Forschungsaktivitäten und klinische Studien angetrieben. Allerdings behindern die hohen Kosten der Arzneimittelentwicklung das Marktwachstum. Allerdings schaffen Schwellenmärkte Wachstumschancen für die Marktteilnehmer.
Lukrative regionale Märkte für Krebsimpfstoffe
Markteinblicke
Anstieg der Krebsprävalenz weltweit
Krebs gehört weltweit zu den häufigsten Todesursachen und beeinträchtigt die Lebensqualität erheblich. Daher wäre Krebs eine Belastung für die Gesellschaft, wenn er nicht rechtzeitig diagnostiziert und behandelt würde. Nach Angaben der Weltgesundheitsorganisation (WHO) waren im Jahr 2018 weltweit etwa 9,6 Millionen Todesfälle auf Krebs zurückzuführen. Darüber hinaus prognostizierte das National Cancer Institute, dass im Jahr 2018 in den USA etwa 1.735.350 neue Krebsfälle diagnostiziert würden. Im Jahr 2018 wurden in Nordamerika etwa 1,9 Millionen neue Krebsfälle und 693.000 Krebstodesfälle registriert. Prostatakrebs ist die am häufigsten diagnostizierte Krebsart bei Männern in Nordamerika; Allerdings bleibt Brustkrebs die häufigste Krebsart bei Frauen. Nach Schätzungen der American Cancer Society ist Brustkrebs die häufigste Krebsart in den USA, da er 2018 bei etwa 234.087 Menschen Morbidität verursachte und zu 41.904 Todesfällen führte. Darüber hinaus werden im Land etwa 276.480 neue Fälle erwartet 2020. Laut dem Globocan-Bericht 2019 betrug die Gesamtzahl der Brustkrebsfälle in Deutschland im Jahr 2018 71.888, und die Krankheit führte in diesem Jahr zu etwa 19.376 Todesfällen. Darüber hinaus ist Lungenkrebs nach wie vor die häufigste Todesursache bei beiden Geschlechtern. Schätzungen zufolge liegt die Zahl der Neuerkrankungen an Krebs bei 439,2 pro 100.000 Männer und Frauen pro Jahr. Laut dem National Health Profile sind die Fälle häufiger Krebserkrankungen, darunter Gebärmutterhals-, Mund- und Brustkrebs, in Indien zwischen 2017 und 2018 um 324 % gestiegen.
Technologiebasierte Erkenntnisse
Auf der Grundlage der Technologie wurde der Markt für Krebsimpfstoffe in Krebsimpfstoffe gegen dendritische Zellen, rekombinante Krebsimpfstoffe, Antigen-Krebsimpfstoffe, Ganzzellkrebsimpfstoffe und virale Vektorkrebsimpfstoffe unterteilt. Das Segment der rekombinanten Krebsimpfstoffe hatte 2019 den größten Marktanteil und wird im Prognosezeitraum voraussichtlich auch die höchste CAGR auf dem Markt verzeichnen.
Markt für Krebsimpfstoffe nach Technologie 2018 und 2027
Typbasierte Erkenntnisse
Der Markt für Krebsimpfstoffe ist nach Typ in präventive Krebsimpfstoffe und unterteilt therapeutische Krebsimpfstoffe. Das Segment der präventiven Krebsimpfstoffe hielt 2019 einen größeren Marktanteil und es wird erwartet, dass es im Prognosezeitraum eine höhere CAGR auf dem Markt verzeichnen wird.
Indikationsbasierte Erkenntnisse
Der Markt für Krebsimpfstoffe ist je nach Indikation in Gebärmutterhalskrebs, Prostatakrebs und andere Indikationen unterteilt. Das Segment Gebärmutterhalskrebs hielt 2019 den größten Marktanteil und der Markt für dieses Segment wird im Prognosezeitraum voraussichtlich die höchste CAGR verzeichnen.
Endbenutzerbasierte Erkenntnisse
Der Markt für Krebsimpfstoffe ist nach Endverbrauchern in Pädiatrie und Erwachsene unterteilt. Das Pädiatrie-Segment hielt 2019 einen größeren Marktanteil und es wird erwartet, dass dasselbe Segment im Prognosezeitraum eine höhere CAGR von 17,4 % verzeichnen wird.
Strategische Einblicke
Produkteinführungen und -zulassungen sind die von Unternehmen häufig angewandten Strategien, um ihre globale Präsenz und ihr Produktportfolio zu erweitern. Diese Strategien helfen ihnen, der wachsenden Verbrauchernachfrage gerecht zu werden. Zusammenarbeit ist eine der wichtigsten Strategien der Marktteilnehmer für Krebsimpfstoffe, um den Kundenstamm weltweit zu vergrößern, was ihnen auch ermöglicht, ihren Markennamen weltweit aufrechtzuerhalten.
Globaler Markt für Krebsimpfstoffe nach Technologie
< ul>
Globaler Markt für Krebsimpfstoffe nach Typ
- Präventive Krebsimpfstoffe
- Therapeutischer Krebsimpfstoff
Globaler Markt für Krebsimpfstoffe nach Indikation
- Gebärmutterhalskrebs
- Prostatakrebs
- Andere Indikationen
Globaler Markt für Krebsimpfstoffe nach Endbenutzer
- Pädiatrie
- Erwachsene
Markt für Krebsimpfstoffe nach Geografie
< ul>
- USA
- Kanada
- Mexiko
< li>Frankreich
< /ul>
- China
- Indien
- Südkorea
- Japan
- Australien
- Übriger Asien-Pazifik-Raum
- Südafrika
- Saudi-Arabien
- VAE
- Übriger Naher Osten und Afrika
- Brasilien
- Argentinien
- Übriges Südamerika
Firmenprofile
- ADURO BIOTECH INC.
- Astellas Pharma Inc.
- Merck & Co., Inc.
- Sanofi
- Bristol-Myers Squibb Company
- Glaxosmithkline Plc.
- Dendreon
- ASTRAZENECA PLC.
- OSE Immunotherapeutics
< li>CSL Limited
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies - Cancer Vaccines Market
- CSL Limited
- ADURO BIOTECH INC.
- Astellas Pharma Inc.
- Merck & Co. Inc.
- Sanofi
- Bristol-Myers Squibb Company
- Glaxosmithkline Plc.
- Dendreon
- ASTRAZENECA PLC.
- OSE Immunotherapeutics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Sep 2020
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Sep 2020
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Sep 2020
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2020
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Sep 2020
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Sep 2020
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)